ClearPoint Neuro, Inc. /
IRRAS Holdings, Inc.
ClearPoint Neuro adds IRRAS to its neurotechnology portfolio
Source for the buyer and target: ClearPoint Neuro, Inc.
For the buyer and target.
“ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it has completed its previously announced acquisition of IRRAS Holdings, Inc. (“IRRAS”).”
Published 20 Nov 2025
Open the sourceWhat happened
ClearPoint Neuro, Inc. completed its acquisition of IRRAS Holdings, Inc. on Nov. 20, 2025. The consideration included $5,000,000 in cash and 1,325,000 shares of Company common stock. [01]
The transaction also provides for a revenue share on net sales of certain IRRAS products for specific periods. The acquisition brings the IRRA flow active fluid-exchange system, designed to modernize the management of intracranial bleeding. [01]
The source
Everything on this page comes from the source below, quoted word for word.
ClearPoint Neuro adds IRRAS to its neurotechnology portfolio
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Closed
“ClearPoint Neuro adds IRRAS to its neurotechnology portfolio ClearPoint Neuro, Inc. completed its acquisition of IRRAS Holdings, Inc. on Nov. 20, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly